Fig. 6.

Effect of dihydromyricetin on TGF-β1-induced migration of pulmonary fibroblasts. (A) Mlg cells were exposed to TGF- β1 (5 ng/ml) or a series dihydromyricetin concentration (0–160 µM) in serum-free medium for 24 h. (B) Mlg cells were treated with TGF-β1 and/or dihydromyricetin (10 µM, 20 µM, 40 µM) for 0, 6, 12, or 24 h. Area analyses are shown beside. Scale bars: 100 µm. Data are shown as mean ± SD. * represent the difference between TGF-β1 treatment and dihydromyricetin-treated group, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.